Business EconomyPosted at: Jul 12 2025 4:15PM


Wockhardt announces exit from generics drugs Business in US

Mumbai, July 12 (UNI) Pharma company Wockhardt stated in a regulatory filing that it will exit from the US generic drugs market.
The move has come after years of sustained losses in the segment, with the company's generics business posting a loss of approximately $8 million in FY25.
Wockhardt stated in a regulatory filing on Friday that it has initiated voluntary liquidation proceedings for its two US subsidiaries, namely Morton Grove Pharmaceuticals Inc and Wockhardt USA LLC, under Chapter 7 of the US Bankruptcy Code. Both the companies incorporated in Delaware, United States, are wholly owned by Wockhardt Bio AG.
Wockhardt’s statement emphasised that the exit from the US generics sector will enhance its ability
to deliver sustainable profitability through innovation and scientific leadership. The company reiterated its commitment to pharmaceutical operations in India, the UK, Ireland, and other international markets, where its businesses continue to perform profitably.
The decision is part of Wockhardt’s broader plan to streamline operations and concentrate on its high-value, innovation-driven product lines. By exiting the US generics market, the company aims
to redirect capital and executive focus toward two key growth areas of novel antibiotics and its biologicals portfolio, particularly in insulin-based therapies.
Earlier, Wockhardt’s founder chairman Habil Khorakiwala had hinted about the move, saying that the company would move away from commoditised generics in the US and concentrate on launching innovative drugs developed in Europe at FDA-approved facilities.
This approach aligns with Wockhardt’s long-term goal of transforming into a research-led pharmaceutical firm with a global footprint, he had stated.
UNI XC BM
Please log in to get detailed story.
Tags: #Wockhardt announces exit from generics drugs Business in US
More News
RBI holds rates at 5 25%, keeps neutral stance as inflation outlook improves

RBI holds rates at 5 25%, keeps neutral stance as inflation outlook improves

07 Feb 2026 | 1:30 AM

Mumbai, Feb 6 (UNI) India’s central bank on Friday kept its key policy rate unchanged and maintained a neutral policy stance, citing easing inflation pressures, strong economic fundamentals, Reserve Bank of India Governor Sanjay Malhotra said after the Monetary Policy Committee (MPC) meeting.

see more..

Indian REITs Association welcomes RBI’s decision to permit bank lending to REITs

07 Feb 2026 | 12:47 AM

Chennai, Feb 6 (UNI) The Indian REITs Association (IRA) on Friday welcomed the Reserve Bank of India’s (RBI) decision to allow banks to lend directly to Real Estate Investment Trusts (REITs).

see more..

Jio triumphs with 333 47 Mbps 5G download speed across Odisha’s Berhampur city

07 Feb 2026 | 12:22 AM

Bhubaneswar, Feb 6 (UNI) Odisha’s leading digital service provider, Reliance Jio, proved its 5G network dominance as it delivered the highest 333.47 Mbps 5G download speed at busy hotspots across Brahmapur city, in the latest independent drive test (IDT) results, published by Telecom Regulatory Authority of India (TRAI).

see more..

India Poised for Global Trade Leadership: Experts at FTCCI Conference

06 Feb 2026 | 10:45 PM

Hyderabad, Feb 6 (UNI) India is well-positioned to emerge as a global trade leader, supported by strong economic fundamentals, demographic advantages, and proactive trade policies, experts said at a high-level conference on Business Resilience & Global Trade Management held here on Friday.

see more..

AP: Japan’s Fukuoka business delegation eyes investment, expansion opportunities at Sri City

06 Feb 2026 | 10:11 PM

Sri City (Tirupati dist), Feb 6 (UNI) In a move highlighting deepening Indo-Japanese economic engagement, a seven-member business delegation from the Fukuoka Foreign Trade Association (FFTA), Fukuoka Prefecture, Japan, visited Sri City on Friday to explore investment opportunities and industrial partnerships.

see more..